Novelix Pharmaceuticals Ltd

📈 Novelix Pharma Raises ₹13.92 Cr via Preferential Issue

• Issued 23,20,000 equity shares at ₹60 each (face value ₹10, premium ₹50).

• Total funds raised: ₹13,92,00,000 (Thirteen Crore Ninety-Two Lakhs).

• Shares allotted to 36 investors, including promoter group and non-promoters.

• Key allottees: Pavani Vupparapalli (3,25,000 shares), Venkataramana Reddy Mallela (3,30,000 shares), Venkatrama Rao Bommaraju (2,00,000 shares).

• Paid-up equity capital increased from ₹17,61,50,000 (17,615,000 shares) to ₹19,93,50,000 (19,935,000 shares).